MYCO-MARKER™

Strategy

Biomonitoring the mycotoxin exposure through blood with FTA cards and feed analysis to quantify the mycotoxin threat, followed by optimizing the mitigation strategy with Escent®.

Composition

• Mixture of clays (including bentonite 1m558)
• Yeast
• Antioxidants
• Hepatic and renal protectors

Application

Biomonitoring the mycotoxin exposure through blood with FTA cards and feed analysis to quantify the mycotoxin threat, followed by optimizing the mitigation strategy with Escent®.

Mode of Action

The Myco-Marker™ service has demonstrated its usefulness as a biomonitoring tool relating exposure to mycotoxins, present symptoms and performance. Escent® technology has several modes of action, all of which have been demonstrated in vivo:

1. Support for the liver and kidneys
2. Prevention of oxidative stress
3. Elevates the immune response
4. Increases detoxification and
5. Adsorbs (myco)toxins: The ability to detoxify and reduce systemic exposure that has been demonstrated through biomarker analysis is especially remarkable.

Benefits

• Easy sampling with just one drop of blood (~ 60μL)
• Reduced animal invasiveness
• Simplified sample transport and storage
• No plasma separation required
• No special procedures or tubes needed